Cargando…

A Novel Expression Signature from the Perspective of Mesenchymal-Epithelial Transition for Hepatocellular Carcinoma with Regard to Prognosis, Clinicopathological Features, Immune Cell Infiltration, Chemotherapeutic Efficacy, and Immunosuppressive Molecules

PURPOSE: Mesenchymal-epithelial transition (MET), a reverse biological process to epithelial-mesenchymal transition (EMT), is involved in tumor metastasis and invasion. However, the role of MET-related genes (MRGs) in hepatocellular carcinoma (HCC) prognosis remains unclear. METHODS: In this researc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Lijun, Zheng, Qing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8342179/ https://www.ncbi.nlm.nih.gov/pubmed/34367283 http://dx.doi.org/10.1155/2021/5033416

Ejemplares similares

A Novel Epithelial-Mesenchymal Transition Gene Signature Correlated With Prognosis, and Immune Infiltration in Hepatocellular Carcinoma
por: Kong, Weihao, et al.
Publicado: (2022)

An epithelial-mesenchymal transition-related 5-gene signature predicting the prognosis of hepatocellular carcinoma patients
por: Zhu, Gongmin, et al.
Publicado: (2021)

A novel epithelial–mesenchymal transition gene signature for the immune status and prognosis of hepatocellular carcinoma
por: Shi, Yanlong, et al.
Publicado: (2022)

Combination of ferroptosis and pyroptosis to construct a prognostic classifier and predict immune landscape, chemotherapeutic efficacy and immunosuppressive molecules in hepatocellular carcinoma
por: Xu, Lijun, et al.
Publicado: (2022)

An epithelial–mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma
por: Zhang, Yu, et al.
Publicado: (2023)

DTYMK Expression Predicts Prognosis and Chemotherapeutic Response and Correlates with Immune Infiltration in Hepatocellular Carcinoma
por: Guo, Yiwen, et al.
Publicado: (2021)

The transcriptome signature analysis of the epithelial-mesenchymal transition and immune cell infiltration in colon adenocarcinoma
por: Heryanto, Yusri Dwi, et al.
Publicado: (2023)

Development and validation of an epithelial–mesenchymal transition-related gene signature for predicting prognosis
por: Zhou, De-Hua, et al.
Publicado: (2022)

Common cytotoxic chemotherapeutics induce epithelial-mesenchymal transition (EMT) downstream of ER stress
por: Shah, Parag P., et al.
Publicado: (2017)

Epithelial-mesenchymal transition-related gene signature for prognosis of lung squamous cell carcinoma
por: Yu, Hongmin, et al.
Publicado: (2023)

PD-L1-Mediated Immunosuppression in Oral Squamous Cell Carcinoma: Relationship With Macrophage Infiltration and Epithelial to Mesenchymal Transition Markers
por: Wu, Tiantian, et al.
Publicado: (2021)

PIK3CD correlates with prognosis, epithelial–mesenchymal transition and tumor immune infiltration in breast carcinoma
por: He, Wenxing, et al.
Publicado: (2023)

Signature of prognostic epithelial–mesenchymal transition related long noncoding RNAs (ERLs) in hepatocellular carcinoma
por: Xu, Bang-Hao, et al.
Publicado: (2021)

Discovery and Validation of an Epithelial-Mesenchymal Transition-Based Signature in Gastric Cancer by Genomics and Prognosis Analysis
por: Xu, Huiyong, et al.
Publicado: (2021)

Identification of a Novel Epithelial–Mesenchymal Transition-Related Gene Signature for Endometrial Carcinoma Prognosis
por: Ruan, Tianyuan, et al.
Publicado: (2022)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Immunotherapy in Gastric Cancer
por: Song, Junquan, et al.
Publicado: (2022)

Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients
por: Huang, Shenglan, et al.
Publicado: (2022)

Musashi2 predicts poor prognosis and invasion in hepatocellular carcinoma by driving epithelial–mesenchymal transition
por: He, Lu, et al.
Publicado: (2014)

GIT1 overexpression promotes epithelial-mesenchymal transition and predicts poor prognosis in hepatocellular carcinoma
por: Wang, Guifu, et al.
Publicado: (2020)

Epithelial-mesenchymal transition (EMT) signature is inversely associated with T-cell infiltration in non-small cell lung cancer (NSCLC)
por: Chae, Young Kwang, et al.
Publicado: (2018)

TNF-α-mediated epithelial-to-mesenchymal transition regulates expression of immune checkpoint molecules in hepatocellular carcinoma
por: Shrestha, Ritu, et al.
Publicado: (2020)

A novel epithelial-mesenchymal transition-related gene signature for prognosis prediction in patients with lung adenocarcinoma
por: Feng, Shengyu, et al.
Publicado: (2022)

Comprehensive Characterization of Immune Landscape Based on Epithelial-Mesenchymal Transition Signature in OSCC: Implication for Prognosis and Immunotherapy
por: Zhang, Si-yuan, et al.
Publicado: (2021)

Metastasis Related Epithelial-Mesenchymal Transition Signature Predicts Prognosis and Response to Chemotherapy in Acute Myeloid Leukemia
por: Qu, Shuang, et al.
Publicado: (2023)

Targeting epithelial-mesenchymal transition pathway in hepatocellular carcinoma
por: Song, Jaewhan
Publicado: (2020)

Epithelial Mesenchymal and Endothelial Mesenchymal Transitions in Hepatocellular Carcinoma: A Review
por: Gurzu, Simona, et al.
Publicado: (2019)

Genomics and Prognosis Analysis of Epithelial-Mesenchymal Transition in Glioma
por: Tao, Chuming, et al.
Publicado: (2020)

Chemotherapeutic Stress Influences Epithelial–Mesenchymal Transition and Stemness in Cancer Stem Cells of Triple-Negative Breast Cancer
por: Li, Xiao, et al.
Publicado: (2020)

Identification of the Pyroptosis-Related Prognosis Gene Signature and Immune Infiltration in Hepatocellular Carcinoma
por: Yu, Heng, et al.
Publicado: (2022)

Assessment of epithelial–mesenchymal transition signatures in oral submucous fibrosis
por: Prasad, R Shesha, et al.
Publicado: (2019)

Epithelial-mesenchymal transition gene signature is associated with prognosis and tumor microenvironment in head and neck squamous cell carcinoma
por: Jung, Ah Ra, et al.
Publicado: (2020)

An epithelial–mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer
por: Tong, Hang, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition Gene Signature Is Associated with Neoadjuvant Chemoradiotherapy Resistance and Prognosis of Esophageal Squamous Cell Carcinoma
por: Song, Kewei, et al.
Publicado: (2022)

Systematic establishment and verification of an epithelial-mesenchymal transition gene signature for predicting prognosis of oral squamous cell carcinoma
por: Ai, Jun, et al.
Publicado: (2023)

Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
por: Yao, Xing, et al.
Publicado: (2012)

Identification of collagen genes related to immune infiltration and epithelial-mesenchymal transition in glioma
por: Yin, Wen, et al.
Publicado: (2021)

High tumor-associated macrophages infiltration is associated with poor prognosis and may contribute to the phenomenon of epithelial–mesenchymal transition in gastric cancer
por: Yan, Yan, et al.
Publicado: (2016)

Actin‐like 6A predicts poor prognosis of hepatocellular carcinoma and promotes metastasis and epithelial‐mesenchymal transition
por: Xiao, Shuai, et al.
Publicado: (2016)

RETRACTED ARTICLE: Sorcin Predicts Poor Prognosis and Promotes Metastasis by Facilitating Epithelial-mesenchymal Transition in Hepatocellular Carcinoma
por: Lei, Xiong, et al.
Publicado: (2017)

PDE4a predicts poor prognosis and promotes metastasis by inducing epithelial-mesenchymal transition in hepatocellular carcinoma
por: Peng, Yanghong, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_guvmubhhn0uvr9ajuao8t20hjk